| PUBCHEM ID |
76963603
|
| UNII |
48XOD8IME0
|
| Preferred Term |
2-(2,2-DIFLUOROETHOXY)-N-(5,6-DIHYDRO-8-METHOXY-5-OXO-(1,2,4)TRIAZOLO (1,5-C)PYRIMIDIN-2-YL)-6-(TRIFLUOROMETHYL)BENZENESULFONAMIDE
|
| CAS |
1041752-25-3
|
| INCHIKEY |
DZTVVDLUWLBGEJ-UHFFFAOYSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
COC(C=N1)=C2N=C(NS(c(c(C(F)(F)F)ccc3)c3OCC(F)F)(=O)=O)NN2C1=O
|
| Total Surface Area |
297,14
|
| Relative PSA |
0,37393
|
| TPSA |
130,07
|
| cLogS |
-5,768
|
| MW |
469,346
|
| cLogP |
0,5646
|
| H-Acceptors |
10
|
| H-Donors |
2
|
| Ro5 violations |
0
|
| Druglikeness |
-3,0894
|
| DrugScore |
0,271694887550766
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,859
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,4961
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5676
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,2872
|
| Carcinogenicity (Three-class) |
Non-required
|
